Who has invested in Anokion?

Pfizer, Versant Ventures, Novartis Venture Fund, Novo Ventures, Bristol-Myers Squibb (CELG) are named among the investors backing Anokion.

Anokion Funding: $160M Raised, Series B (2019)

Anokion funding overview

Anokion is based in Zurich, Switzerland. Anokion has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2019. The round record for Anokion runs through 2019; nothing later has been disclosed. Investors on record include Pfizer, Versant Ventures, Novartis Venture Fund, Novo Ventures, Bristol-Myers Squibb (CELG). 5 distinct backers are named across the disclosed rounds.

Anokion at a glance

Total raised: $160M
Latest round: Series B
Latest round date: September 2019
Headquarters: Zurich, Switzerland
Notable investors: Pfizer, Versant Ventures, Novartis Venture Fund, Novo Ventures, Bristol-Myers Squibb (CELG)

Frequently asked about Anokion funding

How much has Anokion raised?: Anokion has raised $160M in total disclosed funding across the rounds on record.
Who has invested in Anokion?: Pfizer, Versant Ventures, Novartis Venture Fund, Novo Ventures, Bristol-Myers Squibb (CELG) are named among the investors backing Anokion.
What was the latest Anokion funding round?: The most recent disclosed round is a Series B, announced in September 2019.
Where is Anokion based?: Anokion is based in Zurich, Switzerland.
When did Anokion last raise?: The last disclosed Anokion round closed in September 2019 at Series B.

Round data for Anokion is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Zurich and backer lists below.

Anokion Funding: $160M Raised, Series B (2019)

Anokion funding overview

Anokion at a glance

Frequently asked about Anokion funding

Companies related to Anokion (30)

Browse related funding lists (7)